MetrionAIIntelligence

Sign in Register

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading market dashboard

My Watchlist

Sign in to track securities

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Verve Therapeutics, Inc.

VERV

HealthcareNASDAQUS

Sign in to save

$11.13

+$0.03 (+0.27%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

Loading disclosure news

VERV News

News and disclosures filtered by period, publisher, and event group.

1 / 1

Filter options

Period

From

To

Company only

Official only

Event search

Event group

Company announcementsFinancial reportsProspectus, capital raise, listingProfit distribution and paymentsPurchase offersLegal proceedingsTrading and market makerCompany detailsManagementSecurity termsCapital and holdersBoard decisions and meetingsInterested-party transactions

Results

Select a headline to open the full news page in the app.

May 18, 2026, 1:55 PM247wallst.comVERV

Three Biotechs That Are Top Takeover Targets

Financial reports

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious: Mounjaro revenue jumped 125% to $8.66 billion last quarter, the company raised full-year revenue guidance to $82 to $85 billion, and the market cap now sits at roughly $881.8 billion.